PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan; Division of Cardiology, Internal Medicine, Chi-Mei Medical Center, Tainan, 71004, Taiwan; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, 71004, Taiwan. Electronic address: cmcvecho2@gmail.com.\', \'Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.\', \'Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan; Division of Cardiology, Internal Medicine, College of Medicine, National Cheng Kung University Hospital, Tainan, 70401, Taiwan. Electronic address: larry@mail.ncku.edu.tw.\', \'Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan, Taiwan; Department of Physiology, National Cheng Kung University Medical College, Tainan, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan. Electronic address: snwu@mail.ncku.edu.tw.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0014-2999(20)30329-010.1016/j.ejphar.2020.173237
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32525005
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
is ?:relation_isRelatedTo_publication of
?:title
  • Effective block by pirfenidone, an antifibrotic pyridone compound (5-methyl-1-phenylpyridin-2[H-1]-one), on hyperpolarization-activated cation current: An additional but distinctive target.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all